4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000169
EVP, Chief Business Officer sold 5,619 shares at $74.56 ($418,953)
- EVP, Chief Business Officer acquired 10,837 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Baroldi Joseph EVP, Chief Business Officer | 2026-04-15 | Option exercise | +10,837 | 52,154 | D: show line 1 in the form | ||
| Baroldi Joseph EVP, Chief Business Officer | 2026-04-16 | Sale | −5,619 | $74.56 | $418,953 | 46,535 | D: show line 2 in the form |
| Open-market sales · 5,619 sh · avg $74.56 · $418,953 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Baroldi Joseph EVP, Chief Business Officer | 2026-04-15 | Option exercise · Restricted Stock Unit | −10,837 | 48,312 | D: show line 3 in the form |
Loading xslF345X06/edgardoc.xml…